<?xml version="1.0" encoding="UTF-8"?>
<p>Notwithstanding, other authors reported that some genotypes of MVs may exhibit different antigenicity [
 <xref rid="pone.0195256.ref037" ref-type="bibr">37</xref>,
 <xref rid="pone.0195256.ref038" ref-type="bibr">38</xref>] and it has been hypothesized that this could potentially lead to less efficiency of the current vaccine [
 <xref rid="pone.0195256.ref039" ref-type="bibr">39</xref>] or cause genotypic-specific escape to neutralization [
 <xref rid="pone.0195256.ref040" ref-type="bibr">40</xref>â€“
 <xref rid="pone.0195256.ref042" ref-type="bibr">42</xref>].
</p>
